Control of μ opioid receptor expression by modification of cDNA 5'- and 3'-noncoding regions

Molecular Brain Research

Volumn 79, Issue 1-2, 2000, Pages 159-162

  Zöllner, Christian ^a   Johnson, Peter S ^b   Bei Wang, Jia ^c   Roy Jr , Andre J ^b   Layton, Kathleen M ^b   Min Wu, Jun ^b   Surratt, Christopher K ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

Author keywords

Expression; G protein; Morphine; Opioid; Regulation; Untranslated region

Indexed keywords

COMPLEMENTARY DNA; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DELETION MUTANT; GENE EXPRESSION REGULATION; IN VITRO STUDY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOP CODON;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ANIMALS; COS CELLS; DNA, COMPLEMENTARY; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; GENE EXPRESSION REGULATION; HUMANS; RECEPTORS, OPIOID, MU; RECOMBINANT PROTEINS; SEQUENCE DELETION; TRANSFECTION;

EID: 0342323732     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(00)00100-5     Document Type: Article

References (35)

1. Andria M.L., Simon E.J. Localization of promoter elements in the human μ-opioid receptor gene and regulation by DNA methylation. Brain Res. Mol. Brain Res. 70:1999;54-65.
2. Arden J.R., Segredo V., Wang Z., Lameh J., Sadee W. Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged μ-opioid receptor expressed in HEK 293 cells. J. Neurochem. 65:1995;1636-1645.
3. Bare L.A., Mansson E., Yang D. Expression of two variants of the human μ opioid receptor mRNA in SK-N-SH cells and human brain. FEBS Lett. 354:1994;213-216.
4. Belke-Louis G.F., Wehmeyer A., Schulz R. μ-Opioid receptor expression in High Five™ insect cells is regulated by 5′ untranslated region (5′UTR). Life Sci. 64:1999;913-921.
5. Binder R., Horowitz J.A., Basilion J.P., Koeller D.M., Klausner R.D., Harford J.B. Evidence that the pathway of transferrin receptor mRNA degradation involves an endonucleolytic cleavage within the 3′ UTR and does not involve poly(A) tail shortening. EMBO J. 13:1994;1969-1980.
6. Brand A.H., Breeden L., Abraham J., Sternglanz R., Nasmyth K. Characterization of a 'silencer' in yeast: a DNA sequence with properties opposite to those of a transcriptional enhancer. Cell. 41:1985;41-48.
7. Chen C.-Y.A., Chen T.-M., Shyu A.-B. Interplay of two functionally and structurally distinct domains of the c-fos AU-rich element specifies its mRNA-destabilizing function. Mol. Cell Biol. 14:1994;416-426.
8. Chen Y., Mestak A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
9. Dalby B., Glover D.M. Discrete sequence elements control posterior pole accumulation and translational repression of maternal cyclin B RNA in Drosophila. EMBO J. 12:1993;1219-1227.
10. Decker C.J., Parker R. Diversity of cytoplasmic functions for the 3′ untranslated region of eukaryotic transcripts. Curr. Opin. Cell Biol. 7:1995;386-392.
11. Fukuda K., Kato S., Mori K., Nishi M., Takeshima H. Primary structures and expression from cDNAs of rat opioid receptor δ- and μ-subtypes. FEBS Lett. 327:1993;311-314.
12. Goodwin E.B., Okkema P.G., Evans T.C., Kimble J. Translational regulation of tra-2 by its 3′ untranslated region controls sexual identity in C. elegans. Cell. 75:1993;329-339.
13. Graham F.L., van der Eb A.J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-460.
14. Jackson R.J., Standart N. Do the poly(A) tail and 3′ untranslated region control mRNA translation? Cell. 62:1990;15-24.
15. Kao H.-T., Ghafoori S., Porton B., Wong D.L., Ciaranello R.D. Brain specific proteins binding to the 3′ UTR of the 5-HT2C receptor mRNA. Brain Res. Mol. Brain Res. 43:1996;174-184.
16. Koch T., Kroslak T., Mayer P., Raulf E., Hollt V. Site mutation in the rat μ-opioid receptor demonstrates the involvement of calcium/calmodulin-dependent protein kinase II in agonist-mediated desensitization. J. Neurochem. 69:1997;1767-1770.
17. Lee F., Yanofsky C. Transcription termination at the trp operon attenuators of E. coli and S. typhimurium: RNA secondary structure and regulation of termination. Proc. Natl. Acad. Sci. USA. 74:1977;4365-4368.
18. Lowell J.E., Rudner D.Z., Sachs A.B. 3′-UTR-dependent deadenylation by the yeast poly(A) nuclease. Genes Dev. 6:1992;2088-2099.
19. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human μ opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
20. Pan Y.X., Xu J., Bolan E., Abbadie C., Chang A., Zuckerman A., Rossi G., Pasternak G.W. Identification and characterization of three new alternatively spliced μ-opioid receptor isoforms. Mol. Pharmacol. 56:1999;396-403.
21. Peng S.S.-Y., Chen C.-Y.A., Shyu A.-B. Functional characterization of a non-AUUUA AU-rich element from the c-jun proto-oncogene mRNA: evidence for a novel class of AU-rich elements. Mol. Cell Biol. 16:1996;1490-1499.
22. Shaw G., Kamen R. A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell. 46:1986;659-667.
23. Sonenberg N. mRNA translation: influence of the 5′ and 3′ untranslated regions. Curr. Opin. Genet. Dev. 4:1994;310-315.
24. Spivak C.E., Beglan C.L., Seidleck B.K., Hirshbein L.D., Blaschak C.J., Uhl G.R., Surratt C.K. Naloxone activation of μ opioid receptors mutated at a histidine residue lining the opioid binding cavity. Mol. Pharmacol. 52:1997;983-992.
25. Stoecklin G., Hahn S., Moroni C. Functional hierarchy of AUUUA motifs in mediating rapid interleukin-3 mRNA decay. J. Biol. Chem. 269:1994;28591-28597.
26. Tanguay R.L., Gallie D.R. Translational efficiency is regulated by the length of the 3′ untranslated region. Mol. Cell. Biol. 16:1996;146-156.
27. Thompson R.C., Mansour A., Akil H., Watson S.J. Cloning and pharmacological characterization of a rat μ opiate receptor. Neuron. 11:1993;903-913.
28. Wang J.B., Imai Y., Eppler C.M., Gregor P., Spivak C.E., Uhl G.R. μ Opiate receptor: cDNA cloning and expression. Proc. Natl. Acad. Sci. USA. 90:1993;10230-10234.
29. Wang J.B., Johnson P.S., Persico A.M., Hawkins A.L., Griffin C.A., Uhl G.R. Human μ opiate receptor. cDNA and genomic clones, pharmacologic characterization and chromosomal assignment. FEBS Lett. 338:1994;217222.
30. Wilhelm J.E., Vale R.D. RNA on the move: the mRNA localization pathway. J. Cell Biol. 123:1993;269-274.
31. Wilson T., Treisman R. Removal of poly(A) and consequent degradation of c-fos mRNA facilitated by 3′ AU-rich sequences. Nature. 336:1988;396-399.
32. Wormington M. Unmasking the role of the 3′ UTR in the cytoplasmic polyadenylation and translational regulation of maternal mRNAs. Bioessays. 16:1994;533-535.
33. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., Wang J.B. Differential μ opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271:1996;11449-11454.
34. Zimprich A., Simon T., Hollt V. Cloning and expression of an isoform of the rat μ opioid receptor (rMOR1B) which differs in agonist induced desensitization from rMOR1. FEBS Lett. 359:1995;142-146.
35. Zurawski G., Elseviers D., Stauffer G.V., Yanofsky C. Translational control of transcription termination at the attenuator of the Escherichia coli tryptophan operon. Proc. Natl. Acad. Sci. USA. 75:1978;5988-5992.